Related Experiment Video
Updated: Nov 7, 2025

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Patients with Autoimmune Hepatitis Report Lower Lifetime Coffee Consumption
Craig Lammert1, Sai N Chalasani2, Kelsey Green2
1Division of Gastroenterology and Hepatology, Indiana University School of Medicine, 702 Rotary Circle, Suite 205, Indianapolis, IN, 46202, USA. clammert@iu.edu.
Coffee consumption is lower in patients with autoimmune hepatitis (AIH). This study found that AIH patients drank fewer cups of coffee and for a shorter duration than healthy controls.
Area of Science:
- Hepatology
- Autoimmune Diseases
- Epidemiology
Background:
- Coffee consumption is linked to reduced risk of certain autoimmune and liver diseases.
- Environmental factors, including coffee intake, require assessment in autoimmune hepatitis (AIH).
Purpose of the Study:
- To investigate the association between coffee consumption and the risk of developing AIH.
- Utilize the GRACE database to analyze coffee drinking habits in AIH patients and controls.
Main Methods:
- A case-control study involving 358 AIH patients and 564 controls.
- Collected lifetime coffee drinking data (time, frequency, cups) from primary care visits.
- Employed Wilcoxon rank sum and Chi-square tests for group comparisons, with logistic regression for covariate-adjusted analysis.
Main Results:
- AIH patients were less likely to be current coffee drinkers (65.6% vs. 77%) and more likely to be never drinkers (24.6% vs. 15.7%) compared to controls.
- AIH patients who drank coffee consumed fewer cups per month and for a smaller percentage of their lives.
- Lower coffee consumption remained significantly associated with AIH after adjusting for age, sex, BMI, and other lifestyle factors.
Conclusions:
- Coffee consumption is significantly lower among individuals diagnosed with AIH.
- Reduced coffee intake may be a potential environmental factor associated with AIH development.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Drug Excretion: Influencing Factors
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

